EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage

Hazel Dunbar, Ian J Hawthorne, Courteney Tunstead, Molly Dunlop, Evelina Volkova, Daniel J Weiss, Claudia C Dos Santos, Michelle E Armstrong, Seamas C Donnelly, Karen English

European Journal of Immunology · 2025

DOI: 10.1002/eji.202451205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Hazel Dunbar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Co. Kildare, Ireland. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Mesenchymal Stem Cells, Vascular Endothelial Growth Factor A, Pyroglyphidae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council, Higher Education Authority, HEA COVID grant to Maynooth University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancing mesenchymal stromal cell (MSC) therapeutic efficacy through licensing with proinflammatory cytokines is now well established. We have previously shown that macrophage migration inhibitory factor (MIF)‐licensed MSCs exerted significantly enhanced therapeutic efficacy in reducing inflammation in house dust mite (HDM)‐driven allergic asthma. Soluble mediators released into the MSC secretome boast cytoprotective properties equal to those associated with the cell itself. In asthma, epithelial barrier damage caused by the inhalation of allergens like HDM drives goblet cell hyperplasia. Vascular endothelial growth factor (VEGF) plays a pivotal role in the repair and maintenance of airway epithelial integrity. Human bone marrow‐derived MSCs expressed the MIF receptors CD74, CXCR2, and CXCR4. Endogenous MIF from high MIF expressing CATT 7 bone marrow‐derived macrophages increased MSC production of VEGF through the MIF CXCR4 chemokine receptor, where preincubation with CXCR4 inhibitor mitigated this effect. CATT 7 ‐MIF licensed MSC conditioned media containing increased levels of VEGF significantly enhanced bronchial epithelial wound healing via migration and proliferation in vitro. Blocking VEGFR2 or the use of mitomycin C abrogated this effect. Furthermore, CATT 7 ‐MIF MSC CM significantly decreased goblet cell hyperplasia after the HDM challenge in vivo. This was confirmed to be VEGF‐dependent, as the use of anti‐human VEGF neutralising antibody abrogated this effect. Overall, this study highlights that MIF‐licenced MSCs show enhanced production of VEGF, which has the capacity to repair the lung epithelium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage Migration-Inhibitory FactorsMesenchymal Stem CellsVascular Endothelial Growth Factor APyroglyphidaeIntramolecular OxidoreductasesAsthmaAnimalsHumansReceptors, CXCR4MiceAntigens, Differentiation, B-LymphocyteReceptors, Interleukin-8BCell MovementGoblet CellsCells, CulturedMacrophagesHistocompatibility Antigens Class II

Stichwörter der Autor:innen

airway epithelialhouse dust mitemacrophage migration inhibitory factormesenchymal stromal cellsvascular endothelial growth factor

Substanzen

Macrophage Migration-Inhibitory FactorsVascular Endothelial Growth Factor AReceptors, CXCR4Intramolecular OxidoreductasesAntigens, Differentiation, B-LymphocyteMIF protein, humanReceptors, Interleukin-8Binvariant chainCXCR4 protein, humanHistocompatibility Antigens Class II

Autor:innen und Institutionen

  • Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Co. Kildare, Ireland.
  • Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland.
  • Department of Medicine, 226 Health Sciences Research Facility, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
  • The Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, Ontario, Canada.
  • Institute of Medical Sciences and Interdepartmental Division of Critical Care, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medicine, Trinity College Dublin and Tallaght Hospital, Dublin, Ireland.

Förderung

  • Irish Research Council
  • Higher Education Authority
  • HEA COVID grant to Maynooth University
  • Science Foundation Ireland

Zitieren

APA

Dunbar, H., Hawthorne, I. J., Tunstead, C., Dunlop, M., Volkova, E., Weiss, D. J., Santos, C. C. D., Armstrong, M. E., Donnelly, S. C., & English, K. (2025). The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage. European Journal of Immunology. https://doi.org/10.1002/eji.202451205

Vancouver

Dunbar H, Hawthorne IJ, Tunstead C, Dunlop M, Volkova E, Weiss DJ, et al. The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage. European Journal of Immunology. 2025. doi:10.1002/eji.202451205

BibTeX
@article{Dunbar2025,
  author = {Dunbar, Hazel and Hawthorne, Ian J and Tunstead, Courteney and Dunlop, Molly and Volkova, Evelina and Weiss, Daniel J and Santos, Claudia C Dos and Armstrong, Michelle E and Donnelly, Seamas C and English, Karen},
  title = {The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.202451205}
}
Kostenlos starten →